|Bid||44.15 x 1800|
|Ask||44.31 x 1200|
|Day's range||44.22 - 44.81|
|52-week range||40.94 - 61.71|
|Beta (5Y monthly)||0.65|
|PE ratio (TTM)||8.64|
|Earnings date||01 Nov 2022|
|Forward dividend & yield||1.60 (3.63%)|
|Ex-dividend date||03 Nov 2022|
|1y target est||56.81|
Biogen stock rips higher on a promising new drug. Here's what Wall Street is saying.
Data is still scarce on latest COVID-19 boosters
Recently, Zacks.com users have been paying close attention to Pfizer (PFE). This makes it worthwhile to examine what the stock has in store.